ArticleMaterials today. Bio2024

Non-invasive strategy: Developing a topical IL-4Rα-specific nanobody for the treatment of allergic airway diseases.

Taeyoung Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.